Summary:
Calcified pulmonary infarcts
PE is a common disease in the United States, with 170,000 to
650,000 patients experiencing venous thromboembolism annually. The
National Institute of Health estimates that 200,000 to 600,000
patients are hospitalized each year for venous thromboembolism,
with approximate
Diagnosis
Calcified pulmonary infarcts
Discussion
PE is a common disease in the United States, with 170,000 to
650,000 patients experiencing venous thromboembolism annually. The
National Institute of Health estimates that 200,000 to 600,000
patients are hospitalized each year for venous thromboembolism,
with approximately 50,000 deaths annually due to PE.
Underdiagnosis of PE is common. A large study in the United
States in the mid-1970s estimated that only 29% of patients
surviving PE for more than 1 hour had their condition diagnosed and
therapy instituted. This is especially unfortunate for a disease in
which the mortality is five- to six-fold greater among those
patients in whom the diagnosis is missed and the appropriate
therapy is not instituted.
Risk factors-One of the greatest risk factors for deep
venous thrombosis of the lower extremities and secondary PE is
immobilization. An illness such as pneumonia may force an
individual to bed rest, resulting in the distinct possibility that
a patient may present with PE as a complication of the disease. The
most common risk factors for PE include age, previous venous
thromboembolism, prolonged immobility or paralysis, malignancy,
congestive failure, estrogen use, trauma, pregnancy, obesity, and
surgery.
Clinical symptomatology-Symptoms are not rare in PE,
but are simply nonspecific. A number of clinical series have
reported the incidence of various symptoms and signs among patients
proven to have PE. When these studies are reviewed, the lack of
specificity of any symptom or sign is apparent. The most common
symptoms in a patient with PE are dyspnea, pleuritic chest pain,
apprehension, and cough. Unfortunately any or all of these may
result from a variety of cardiopulmonary disorders. Can patients
with significant PE lack suggested pulmonary symptoms?
Unfortunately, the answer is certainly "yes."
Diagnostic study: Chest radiograph-A chest radiograph
is an essential part of the work-up of all patients suspected of
having PE. Its major value is in eliminating from diagnostic
consideration other entities that may mimic the presentation of
acute PE, such as pneumothorax. The case presented above
demonstrates these focal parenchymal infiltrates. Their wedge shape
lends some specificity to the diagnosis of PE; however, this is by
no means diagnostic.
Diagnostic study: Ventilation-perfusion lung
scan-Ventilation-perfusion lung scanning (V/Q) is the
cornerstone test for PE diagnosis, and our understanding of its
proper role has increased with well designed studies. The PIOPED
trial showed that V/Q lung scan is sensitive and, in some cases,
specific for PE. Among patients with PE confirmed by angiography,
97% had abnormal V/Q scans of high, intermediate, or low
probability. Of cases of proven PE, 41% had highprobability lung
scans. Of all patients with high-probability lung scans, 88% were
shown to have PE by a pulmonary angiogram. The level of clinical
suspicion combined with the V/Q scan is often enough to raise or
lower the possibility of venous thromboembolism sufficiently to
make the decision to treat or to not treat.
Diagnostic study: Pulmonary angiography-Pulmonary
angiography is considered by many to be the gold standard for the
diagnosis of PE, with both sensitivity and specificity > 90%.
However, it is an invasive examination and is not without risk,
especially since these patients are often acutely ill. This
examination can be used when there is clinical concern of PE, yet
not enough data to support anticoagulation in an acutely ill
patient. In the event of an intermediate-probability V/Q scan, fast
CT scanning can be used directly to visualize the pulmonary emboli
as a substitute to pulmonary angiography. Initial experience has
met with considerable success; however, the true sensitivity and
specificity of the examination has yet to be determined in large
clinical trials. Its major pitfall is the inability to visualize
beyond fourth-order branches of the pulmonary artery and, hence,
small distal emboli can be missed.
- Siegel BAPronto AV, Theras EG, et al: Nuclear Radiology (Fourth
Series) Test and Syllabus. Reston, VA: American College of
Radiolog. p. 51, 1990.
- Hampson NB, Culver BH: Clinical aspects of pulmonary embolism.
Semin Ultrasound CTMR. 18:314-322, 1997.
- Hockberger RS, Rothstein R: Pulmonary embolism. Emerg Med Clin
North Am. 1:393-415, 1983.
- Palevsky HI: The problems of the clinical and laboratory
diagnosis of pulmonary embolism. Semin Nuc Med 21:276-280,
1991.